FlnA and its proteolytic fragments directly interact with AR, thereby modulating nuclear translocation and transcriptional action of AR as well as androgen dependence of prostate cancer LNCaP cells [9], [10], [11]. The gene discussed is FLNA; the disease is prostate carcinoma.